Not currently recruiting at UCLA
A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients with Advanced Solid Tumours
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Santa Monica, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Jonathan Goldman, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Jonathan Goldman, MD
Hs Clinical Professor, Medicine. Authored (or co-authored) 112 research publications
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Fusion Pharmaceuticals Inc.
- ID
- NCT06147037
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 110 study participants
- Last Updated